| Original language | English |
|---|---|
| Pages (from-to) | 493-496 |
| Number of pages | 4 |
| Journal | Leukemia and Lymphoma |
| Volume | 59 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2018 |
Cite this
}
Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemia. / Tiong, Ing Soo; Tan, Peter; McManus, Julie; Cummings, Nik; Sadawarte, Sonali; Catalano, John; Hills, Robert; Wei, Andrew.
In: Leukemia and Lymphoma, Vol. 59, No. 2, 2018, p. 493-496.Research output: Contribution to journal › Letter › Research › peer-review
TY - JOUR
T1 - Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemia
AU - Tiong, Ing Soo
AU - Tan, Peter
AU - McManus, Julie
AU - Cummings, Nik
AU - Sadawarte, Sonali
AU - Catalano, John
AU - Hills, Robert
AU - Wei, Andrew
PY - 2018
Y1 - 2018
UR - http://www.scopus.com/inward/record.url?scp=85020444787&partnerID=8YFLogxK
U2 - 10.1080/10428194.2017.1334122
DO - 10.1080/10428194.2017.1334122
M3 - Letter
VL - 59
SP - 493
EP - 496
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
SN - 1042-8194
IS - 2
ER -